CVS Health
(NYSE) CVS
CVS Health Financials at a Glance
Market Cap
$133.54B
Revenue (TTM)
$407.91B
Net Income (TTM)
$2.93B
EPS (TTM)
$2.28
P/E Ratio
45.96
Dividend
$2.66
Beta (Volatility)
0.46 (Low)
Dividend
$2.66
Beta (Volatility)
0.46 (Low)
Price
$104.39
Volume
334,912
Open
$104.57
Price
$104.39
Volume
334,912
Open
$104.57
Previous Close
$104.39
Daily Range
$103.55 - $106.13
52-Week Range
$58.50 - $106.13
Estimated Earnings Date
Jul 30, 2026
Dividend
$2.66
Beta (Volatility)
0.46 (Low)
Price
$104.39
Volume
334,912
Open
$104.57
Previous Close
$104.39
Daily Range
$103.55 - $106.13
52-Week Range
$58.50 - $106.13
Estimated Earnings Date
Jul 30, 2026
CVS News
CVS: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout CVS Health
Industry
Healthcare Providers and Services
Sector
Health CareEmployees
300,000
CEO
J. David Joyner
Website
www.cvshealth.comHeadquarters
Woonsocket, RI 02895, US
CVS Financials
Key Financial Metrics (TTM)
Gross Margin
13.87%
Operating Margin
1.46%
Net Income Margin
0.72%
Return on Equity
3.87%
Return on Capital
6.15%
Return on Assets
1.16%
Earnings Yield
2.18%
Dividend Yield
2.54%
Payout Ratio
1.16%
Stock Overview
Market Cap
$133.54B
Shares Outstanding
1.28B
Volume
334.91K
Avg. Volume
8.25M
Financials (TTM)
Gross Profit
$56.59B
Operating Income
$5.97B
EBITDA
$11.13B
Operating Cash Flow
$10.33B
Capital Expenditure
-$2.94B
Free Cash Flow
$7.39B
Cash & ST Invst.
$11.80B
Total Debt
$78.35B
CVS Health Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$100.43B
+6.2%
Gross Profit
$15.62B
+8.5%
Gross Margin
15.56%
N/A
Market Cap
$133.54B
N/A
Market Cap/Employee
$445.13K
N/A
Employees
300,000
N/A
Net Income
$2.94B
+65.4%
EBITDA
$5.83B
+27.9%
Quarterly Fundamentals
Total Cash
$11.80B
-6.7%
Total Debt
$78.35B
-3.5%
Accounts Receivable
$40.99B
+3.4%
Inventory
$17.77B
+2.2%
Long Term Debt
$73.86B
+0.3%
Short Term Debt
$4.48B
-40.8%
Return on Assets
1.16%
N/A
Return on Invested Capital
3.58%
N/A
Free Cash Flow
$3.40B
-10.8%
Operating Cash Flow
$4.25B
-6.7%